J. Magae et al., TRANSCRIPTIONAL SQUELCHING BY ECTOPIC EXPRESSION OF E2F-1 AND P53 IS ALLEVIATED BY PROTEASOME INHIBITORS MG-132 AND LACTACYSTIN, Oncogene, 15(7), 1997, pp. 759-769
The transcription factors p53 and E2F-1 play important roles in the co
ntrol of cell cycle progression. In transient transfection experiments
, expression of E2F-1, other E2F family members, or p53 squelched tran
scription from cotransfected plasmids in a dose-dependent manner, Alth
ough the proteasome inhibitors MG-132 and lactacystin markedly increas
ed the level of expression of E2F-1 and p53, these inhibitors complete
ly alleviated squelching by both proteins, Several observations indica
te MG-132 alleviates squelching by influencing the conformation of new
ly synthesized p53 and E2F-1 MG-132 increased the fraction of wild typ
e p53 bound by a monoclonal antibody which preferentially recognizes m
utant conformers of p53, increased binding of hsp70 to p53 and inhibit
ed nuclear accumulation of both p53 and E2F-1, but not the pocket prot
ein p107, The protease inhibitors ALLN and ALLM did not influence expr
ession of E2F-1 or p53, nor did they alleviate squelching by either tr
anscription factor, Because MG-132 and lactacycstin are highly specifi
c inhibitors of the proteasome protease, our results suggest that the
proteasome influences post-translational processes involved in proper
folding and cytoplasmic clearing of E2F-1 and p53.